NovMetaPharma Co., Ltd. agreed to acquire SK Securities No.8 Special Purpose Acquisition Company (KOSDAQ:A435870) in a reverse merger transaction on July 27, 2023. The consideration will consist of 88.4 million stock, and 1.37 million as preferred stock, at an exchange ratio of 0.125471. The transaction is expected to complete on March 5, 2024. The expected merger date is June 24, 2024. The deal is expected to be completed on July 30, 2024.

NovMetaPharma Co., Ltd. cancelled the acquisition of SK Securities No.8 Special Purpose Acquisition Company (KOSDAQ:A435870) in a reverse merger transaction on May 27, 2024.